- Lobbying
- Patricia AND Knight
Lobbying Arrangements Results for 'Patricia Knight'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details educational issues/ Visas |
HOLLAND & KNIGHT LLP
|
PATRICIA LYNCH ASSOCIATES | |||
Details Retirement Security, Entitlement Reform |
CNO Financial Group
Insurance |
Knight Capitol Consultants | |||
Details Controlled Substances Act provisions relating to the distribution of medication assisted therapies (The Protecting Patient Access to Emergency Medications Act, S. 916/H.R. 304. Adequacy of funding... |
Braeburn Pharmaceuticals, Inc.
|
Knight Capitol Consultants | |||
Details Coverage for substance abuse and mental health services in legislation to repeal/replace the Affordable Care Act (American Health Care Act HR 1628); adequacy of health care coverage for pain therap... |
Pernix Therapeutics Holdings, LLC
|
Knight Capitol Consultants | |||
Details Draft Food and Drug Administration Globalization Act (Rep. Dingell) |
SAP America, Inc.
|
Knight Capitol Consultants | |||
Details Monitor NIOSH proceedings with respect to worker safety and closed-system transfer devices. |
Equashield, LLC
|
Knight Capitol Consultants | |||
Details No specific bills: matters relating to private mortgage insurance |
Holland & Knight
|
The OB-C Group. LLC | |||
Details Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860) Potentia... |
United Natural Products Alliance
|
Knight Capitol Consultants | |||
Details Education about the necessity and safety of vaccines and their role in preventing childhood disease. Issues related to pharmaceutical pricing in general (no specific legislation) |
Sanofi US Services, Inc. (formerly known as "sanofi-aventis U.S. Inc.)
|
Knight Capitol Consultants | |||
Details Potential issues of interest to the life insurance industry, including those affecting retirement savings, in the infrastructure/reconciliation legislation now being considered (Infrastructure, In... |
CNO Financial Group
|
Knight Capitol Consultants | |||
Details Access to medication-assisted therapy for opioid overuse, and the use of telemedicine for provision of services (HR 4531, Support for Patients and Communities Reauthorization/ no Senate number yet ... |
Indivior, Inc.
|
Knight Capitol Consultants | |||
Details Funding for research and clinical trials related to long term studies of COVID-19 at the National Institutes of Health provided in the Consolidated Appropriations Act of 2021 (PL 116-260); Funding ... |
Perspectum
|
Knight Capitol Consultants | |||
Details Issues affecting biotechnology firms engaged in developing gene therapies, including: the MVP Act (H.R.2666) authorizing value based payments under the Medicaid program; Proposals to amend the drug... |
ReGenxBio
|
Knight Capitol Consultants | |||
Details Implementation and possible change/repeal to provisions related to the Patient Protection and Affordable Care Act (PL 111-178) and the Reconciliation Act (PL 111-152), including implementation of b... |
Genzyme Corporation
|
Knight Capitol Consultants | |||
Details Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals |
Grifols Inc.
|
SIDLEY AUSTIN LLP | |||
Details Patent Reform Act of 2011 (S. 23) |
PhRMA
|
Knight Capitol Consultants | |||
Details Prudential agency (Federal Reserve, OCC and FDIC) proposal to implement the Basel Endgame reforms in the U.S. and congressional (U.S. House and Senate) oversight of the same, including revisions to... |
Securities Industry and Financial Markets Association
|
in-house lobbying |